METACRINE

Metacrine, Inc.

Application Filed: 2018-08-23
Trademark Application Details
Trademark Logo METACRINE

Mark For: METACRINE® trademark registration is intended to cover the categories of pharmaceutical research and development; pharmaceutical products development; research and development in the field of pharmaceutical drug development and discovery regarding the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders; pharmaceutical research regarding treatment of irritable bowel syndrome, inflammatory bowel disease, and non-alcoholic steatohepatitis (NASH). [all]

Status

2021-06-24 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88090317
Registration Number5720963
Mark Literal ElementsMETACRINE
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeSERVICE MARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2019-04-09
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseYes
Current UseYes
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJohn Paul Oleksiuk
Attorney Docket Number323261-20000
Law Office AssignedL30
Employee NameCOHEN, ROBERT A

Timeline

2018-05-29Date of First Use
2018-05-29Date of Use In Commerce
2018-08-23Application Filed
2018-12-14Location: PUBLICATION AND ISSUE SECTION
2018-12-14Status: Live/Pending
2019-01-02Transaction Date
2019-01-22Published
2019-01-22Published for Opposition
2019-04-09Location: PUBLICATION AND ISSUE SECTION
2019-04-09Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-04-09Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Metacrine, Inc.
Address3985 Sorrento Valley Blvd, Suite C San Diego, CALIFORNIA UNITED STATES 92121
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingIMAGE/JPEG2018-08-23
SpecimenIMAGE/JPEG2018-08-23
TEAS RF New ApplicationAPPLICATION/XML,IMAGE/JPEG2018-08-23
Notation to FileAPPLICATION/XML2018-12-12
XSearch Search SummaryAPPLICATION/XML2018-12-12
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2018-12-13
Notice of PublicationAPPLICATION/XML2019-01-02
Notification Of Notice of PublicationAPPLICATION/XML2019-01-02
OG Publication ConfirmationAPPLICATION/XML2019-01-22
Registration CertificateAPPLICATION/PDF2019-04-09

Attorney of Record

JOHN PAUL OLEKSIUK
COOLEY LLP
1299 PENNSYLVANIA AVENUE, NW, SUITE 700
WASHINGTON, DC 20004-2400

Good, Services, and Codes


IC 042. US 100 101. G & S: pharmaceutical research and development; pharmaceutical products development; research and development in the field of pharmaceutical drug development and discovery regarding the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders; pharmaceutical research regarding treatment of irritable bowel syndrome, inflammatory bowel disease, and non-alcoholic steatohepatitis (NASH). FIRST USE: 20180529. FIRST USE IN COMMERCE: 20180529

International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421pharmaceutical research and development; pharmaceutical products development; research and development in the field of pharmaceutical drug development and discovery regarding the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders; pharmaceutical research regarding treatment of irritable bowel syndrome, inflammatory bowel disease, and non-alcoholic steatohepatitis (NASH)
GS0421pharmaceutical research and development; pharmaceutical products development; research and development in the field of pharmaceutical drug development and discovery regarding the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders; pharmaceutical research regarding treatment of irritable bowel syndrome, inflammatory bowel disease, and non-alcoholic steatohepatitis (NASH)

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2019-04-09
PUBLISHED FOR OPPOSITION2019-01-22
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-01-22
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-01-02
APPROVED FOR PUB - PRINCIPAL REGISTER2018-12-12
ASSIGNED TO EXAMINER2018-12-0792448
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-09-01
NEW APPLICATION ENTERED IN TRAM2018-08-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed